Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased platelet phospholipase A2 activity in schizophrenia

W F Gattaz1, A Schmitt, A Maras

  • 1Neurobiology Unit, Central Institute of Mental Health, Mannheim, Germany.

Schizophrenia Research
|July 1, 1995
PubMed
Summary

Platelet phospholipase A2 (PLA2) activity is elevated in schizophrenia, suggesting accelerated membrane phospholipid breakdown. Neuroleptic treatment reduced this enzyme activity, offering potential therapeutic insights for this mental health condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond the LRINEC Score: A stratified diagnostic algorithm for subacute and atypical necrotizing fasciitis.

Annales de chirurgie plastique et esthetique·2026
Same author

The Absence of Claudin-10 in the Enamel Organ Alters Its Integrity.

Journal of dental research·2025
Same author

Primary central nervous system lymphoma of the spinal cord: A LOC network cohort study.

Revue neurologique·2024
Same author

CDK9 inhibition as an effective therapy for small cell lung cancer.

Cell death & disease·2024
Same author

Expanding self-consciousness of health status for diabetes chronic complications among adults: a systematic review.

European review for medical and pharmacological sciences·2024
Same author

Effect of managed transition on mental health outcomes for young people at the child-adult mental health service boundary: a randomised clinical trial.

Psychological medicine·2023

Area of Science:

  • Biochemistry
  • Neuroscience
  • Psychiatry

Background:

  • Intracellular phospholipase A2 (PLA2) is crucial for membrane phospholipid metabolism.
  • PLA2 influences brain receptor function, signal transduction, and dopaminergic neurotransmission.
  • Previous studies suggest PLA2 activation may reduce dopaminergic neurotransmission.

Purpose of the Study:

  • To investigate intracellular PLA2 activity in platelets of paranoid schizophrenic patients.
  • To compare PLA2 activity in schizophrenic patients with healthy and non-schizophrenic psychiatric controls.
  • To assess the effect of neuroleptic treatment on platelet PLA2 activity.

Main Methods:

  • Platelet PLA2 activity was measured in 31 DSM-III-R paranoid schizophrenic patients (15 neuroleptic-naive).

Related Experiment Videos

  • Controls included 31 healthy individuals and 31 non-schizophrenic psychiatric patients, matched for age and sex.
  • Enzyme activity was compared between groups, and the effect of neuroleptic treatment was analyzed.

    • Main Results:

    • Platelet PLA2 activity was significantly increased in schizophrenic patients compared to both healthy and psychiatric controls.
    • Neuroleptic treatment was associated with a significant reduction in platelet PLA2 activity.
    • These findings suggest an accelerated breakdown of membrane phospholipids in schizophrenia.

    Conclusions:

    • Increased platelet PLA2 activity in schizophrenia may indicate accelerated phospholipid metabolism.
    • The observed reduction in PLA2 activity with neuroleptic treatment warrants further investigation.
    • Further research is needed to determine if elevated brain PLA2 contributes to frontal dysfunction in schizophrenia.